Loading…

Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation

The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D,

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2003-11, Vol.88 (11), p.5175-5179
Main Authors: Grados, Franck, Brazier, Michel, Kamel, Saïd, Mathieu, Marc, Hurtebize, Nathalie, Maamer, Mohamed, Garabédian, Michèle, Sebert, Jean-Luc, Fardellone, Patrice
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683
cites cdi_FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683
container_end_page 5179
container_issue 11
container_start_page 5175
container_title The journal of clinical endocrinology and metabolism
container_volume 88
creator Grados, Franck
Brazier, Michel
Kamel, Saïd
Mathieu, Marc
Hurtebize, Nathalie
Maamer, Mohamed
Garabédian, Michèle
Sebert, Jean-Luc
Fardellone, Patrice
description The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D,
doi_str_mv 10.1210/jc.2002-021968
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71338823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71338823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxSMEoqVw5Yh8gVsW23Hs5Ahb_lQqooJSuFmOPWG9dexgJ1rtd-JD4m5WKheEJcsaze89j-YVxXOCV4QS_HqrVxRjWmJKWt48KE5Jy-pSkFY8LE5zg5StoD9OiicpbTEmjNXV4-KEMI6pYPy0-H0VwVg92eBR6NHb4AF9Uimhc_DJTnt0o6JVh3a3X9pfYAgGnPU_MxlvISZkPboKaRrAh1HNSTn0PeQC7ey0QTd2UkMmztGFT3PfW23B6z26jqAmMAu0Vk7beUDKm78EX-dxdJCdpsMIT4tHvXIJnh3fs-Lb-3fX64_l5ecPF-s3l6VmTdWWtWh5TTpoBGYda7Ehfd2ZWjdAWYcrLhgxQmBTCd7TzhCjG4WBU55X1WHeVGfFq8V3jOHXDGmSg00anFMewpykIFXVNLT6L0haygk_OK4WUMeQUoRejtEOKu4lwfIuSLnV8i5IuQSZBS-OznM3gLnHj8ll4OURUEkr10fltU33XE3rhlV15tjC7YKbcla3bt5BlBtQbtpInA_joinz3xUhuSrzJW2W1YsMvAk6Wg9jhJTkNszR593_a-4_5YDItQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19261668</pqid></control><display><type>article</type><title>Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation</title><source>Oxford Journals Online</source><creator>Grados, Franck ; Brazier, Michel ; Kamel, Saïd ; Mathieu, Marc ; Hurtebize, Nathalie ; Maamer, Mohamed ; Garabédian, Michèle ; Sebert, Jean-Luc ; Fardellone, Patrice</creator><creatorcontrib>Grados, Franck ; Brazier, Michel ; Kamel, Saïd ; Mathieu, Marc ; Hurtebize, Nathalie ; Maamer, Mohamed ; Garabédian, Michèle ; Sebert, Jean-Luc ; Fardellone, Patrice</creatorcontrib><description>The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D, &lt;12 ng/ml). One hundred and ninety-two women (mean age, 75 ± 7 yr) were randomized to receive either the supplementation (n = 95) or a placebo (n = 97) in a double-blind, controlled clinical trial for 1 yr. In comparison with the placebo group, supplementation significantly increased BMD, normalized 25-hydroxyvitamin D and significantly decreased intact PTH and bone remodeling markers. The initial values of telopeptide cross-links were correlated with improvement in total body BMD [urinary N-telopeptides (NTX), r = 0.38; C-telopeptides (CTX), r = 0.32; serum CTX, r = 0.28], and the 3-month changes in the same markers were correlated with improvement in total body (urinary N-telopeptides, r = −0.29; serum CTX, r = −0.26) and vertebral BMD (CTX, r = −0.26; all P &lt; 0.05). We concluded that short-term changes in bone resorption markers can predict long-term variations in BMD in elderly women with vitamin D insufficiency receiving calcium and vitamin D supplementation.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2002-021968</identifier><identifier>PMID: 14602746</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers ; Bone Density ; Bone Remodeling - drug effects ; Calcium - administration &amp; dosage ; Diseases of the osteoarticular system ; Female ; General and cellular metabolism. Vitamins ; Humans ; Medical sciences ; Osteoporosis, Postmenopausal - drug therapy ; Osteoporosis. Osteomalacia. Paget disease ; Pharmacology. Drug treatments ; Postmenopause ; Predictive Value of Tests ; Treatment Outcome ; Vitamin D - administration &amp; dosage ; Vitamin D Deficiency - drug therapy</subject><ispartof>The journal of clinical endocrinology and metabolism, 2003-11, Vol.88 (11), p.5175-5179</ispartof><rights>Copyright © 2003 by The Endocrine Society</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683</citedby><cites>FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15258435$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14602746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grados, Franck</creatorcontrib><creatorcontrib>Brazier, Michel</creatorcontrib><creatorcontrib>Kamel, Saïd</creatorcontrib><creatorcontrib>Mathieu, Marc</creatorcontrib><creatorcontrib>Hurtebize, Nathalie</creatorcontrib><creatorcontrib>Maamer, Mohamed</creatorcontrib><creatorcontrib>Garabédian, Michèle</creatorcontrib><creatorcontrib>Sebert, Jean-Luc</creatorcontrib><creatorcontrib>Fardellone, Patrice</creatorcontrib><title>Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D, &lt;12 ng/ml). One hundred and ninety-two women (mean age, 75 ± 7 yr) were randomized to receive either the supplementation (n = 95) or a placebo (n = 97) in a double-blind, controlled clinical trial for 1 yr. In comparison with the placebo group, supplementation significantly increased BMD, normalized 25-hydroxyvitamin D and significantly decreased intact PTH and bone remodeling markers. The initial values of telopeptide cross-links were correlated with improvement in total body BMD [urinary N-telopeptides (NTX), r = 0.38; C-telopeptides (CTX), r = 0.32; serum CTX, r = 0.28], and the 3-month changes in the same markers were correlated with improvement in total body (urinary N-telopeptides, r = −0.29; serum CTX, r = −0.26) and vertebral BMD (CTX, r = −0.26; all P &lt; 0.05). We concluded that short-term changes in bone resorption markers can predict long-term variations in BMD in elderly women with vitamin D insufficiency receiving calcium and vitamin D supplementation.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Bone Density</subject><subject>Bone Remodeling - drug effects</subject><subject>Calcium - administration &amp; dosage</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Osteoporosis, Postmenopausal - drug therapy</subject><subject>Osteoporosis. Osteomalacia. Paget disease</subject><subject>Pharmacology. Drug treatments</subject><subject>Postmenopause</subject><subject>Predictive Value of Tests</subject><subject>Treatment Outcome</subject><subject>Vitamin D - administration &amp; dosage</subject><subject>Vitamin D Deficiency - drug therapy</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxSMEoqVw5Yh8gVsW23Hs5Ahb_lQqooJSuFmOPWG9dexgJ1rtd-JD4m5WKheEJcsaze89j-YVxXOCV4QS_HqrVxRjWmJKWt48KE5Jy-pSkFY8LE5zg5StoD9OiicpbTEmjNXV4-KEMI6pYPy0-H0VwVg92eBR6NHb4AF9Uimhc_DJTnt0o6JVh3a3X9pfYAgGnPU_MxlvISZkPboKaRrAh1HNSTn0PeQC7ey0QTd2UkMmztGFT3PfW23B6z26jqAmMAu0Vk7beUDKm78EX-dxdJCdpsMIT4tHvXIJnh3fs-Lb-3fX64_l5ecPF-s3l6VmTdWWtWh5TTpoBGYda7Ehfd2ZWjdAWYcrLhgxQmBTCd7TzhCjG4WBU55X1WHeVGfFq8V3jOHXDGmSg00anFMewpykIFXVNLT6L0haygk_OK4WUMeQUoRejtEOKu4lwfIuSLnV8i5IuQSZBS-OznM3gLnHj8ll4OURUEkr10fltU33XE3rhlV15tjC7YKbcla3bt5BlBtQbtpInA_joinz3xUhuSrzJW2W1YsMvAk6Wg9jhJTkNszR593_a-4_5YDItQ</recordid><startdate>200311</startdate><enddate>200311</enddate><creator>Grados, Franck</creator><creator>Brazier, Michel</creator><creator>Kamel, Saïd</creator><creator>Mathieu, Marc</creator><creator>Hurtebize, Nathalie</creator><creator>Maamer, Mohamed</creator><creator>Garabédian, Michèle</creator><creator>Sebert, Jean-Luc</creator><creator>Fardellone, Patrice</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>200311</creationdate><title>Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation</title><author>Grados, Franck ; Brazier, Michel ; Kamel, Saïd ; Mathieu, Marc ; Hurtebize, Nathalie ; Maamer, Mohamed ; Garabédian, Michèle ; Sebert, Jean-Luc ; Fardellone, Patrice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Bone Density</topic><topic>Bone Remodeling - drug effects</topic><topic>Calcium - administration &amp; dosage</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Osteoporosis, Postmenopausal - drug therapy</topic><topic>Osteoporosis. Osteomalacia. Paget disease</topic><topic>Pharmacology. Drug treatments</topic><topic>Postmenopause</topic><topic>Predictive Value of Tests</topic><topic>Treatment Outcome</topic><topic>Vitamin D - administration &amp; dosage</topic><topic>Vitamin D Deficiency - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grados, Franck</creatorcontrib><creatorcontrib>Brazier, Michel</creatorcontrib><creatorcontrib>Kamel, Saïd</creatorcontrib><creatorcontrib>Mathieu, Marc</creatorcontrib><creatorcontrib>Hurtebize, Nathalie</creatorcontrib><creatorcontrib>Maamer, Mohamed</creatorcontrib><creatorcontrib>Garabédian, Michèle</creatorcontrib><creatorcontrib>Sebert, Jean-Luc</creatorcontrib><creatorcontrib>Fardellone, Patrice</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grados, Franck</au><au>Brazier, Michel</au><au>Kamel, Saïd</au><au>Mathieu, Marc</au><au>Hurtebize, Nathalie</au><au>Maamer, Mohamed</au><au>Garabédian, Michèle</au><au>Sebert, Jean-Luc</au><au>Fardellone, Patrice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2003-11</date><risdate>2003</risdate><volume>88</volume><issue>11</issue><spage>5175</spage><epage>5179</epage><pages>5175-5179</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D, &lt;12 ng/ml). One hundred and ninety-two women (mean age, 75 ± 7 yr) were randomized to receive either the supplementation (n = 95) or a placebo (n = 97) in a double-blind, controlled clinical trial for 1 yr. In comparison with the placebo group, supplementation significantly increased BMD, normalized 25-hydroxyvitamin D and significantly decreased intact PTH and bone remodeling markers. The initial values of telopeptide cross-links were correlated with improvement in total body BMD [urinary N-telopeptides (NTX), r = 0.38; C-telopeptides (CTX), r = 0.32; serum CTX, r = 0.28], and the 3-month changes in the same markers were correlated with improvement in total body (urinary N-telopeptides, r = −0.29; serum CTX, r = −0.26) and vertebral BMD (CTX, r = −0.26; all P &lt; 0.05). We concluded that short-term changes in bone resorption markers can predict long-term variations in BMD in elderly women with vitamin D insufficiency receiving calcium and vitamin D supplementation.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>14602746</pmid><doi>10.1210/jc.2002-021968</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2003-11, Vol.88 (11), p.5175-5179
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_71338823
source Oxford Journals Online
subjects Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers
Bone Density
Bone Remodeling - drug effects
Calcium - administration & dosage
Diseases of the osteoarticular system
Female
General and cellular metabolism. Vitamins
Humans
Medical sciences
Osteoporosis, Postmenopausal - drug therapy
Osteoporosis. Osteomalacia. Paget disease
Pharmacology. Drug treatments
Postmenopause
Predictive Value of Tests
Treatment Outcome
Vitamin D - administration & dosage
Vitamin D Deficiency - drug therapy
title Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A48%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediction%20of%20Bone%20Mass%20Density%20Variation%20by%20Bone%20Remodeling%20Markers%20in%20Postmenopausal%20Women%20with%20Vitamin%20D%20Insufficiency%20Treated%20with%20Calcium%20and%20Vitamin%20D%20Supplementation&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Grados,%20Franck&rft.date=2003-11&rft.volume=88&rft.issue=11&rft.spage=5175&rft.epage=5179&rft.pages=5175-5179&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2002-021968&rft_dat=%3Cproquest_cross%3E71338823%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4839-579651be8704b490d1f5bd5c8e24b036741d770d376f2bd1dc8a0e626972b0683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19261668&rft_id=info:pmid/14602746&rfr_iscdi=true